QuadMedicine, Inc. (KOSDAQ:464490)

Market Cap	151.22B
Revenue (ttm)	10.70B +15.0%
Net Income	-6.93B
EPS	-722.00
Shares Out	11.48M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	156,082
Average Volume	170,487
Open	14,500
Previous Close	14,300
Day's Range	12,910 - 14,500
52-Week Range	12,460 - 27,150
Beta	n/a
RSI	39.39
Earnings Date	n/a

About QuadMedicine

QuadMedicine, Inc. engages in research, development, and production of healthcare vaccination needles based on the microneedle array patch (MAP). The company develops vaccinations for children living in remote areas to protect them from infectious diseases, such as diphtheria, tetanus, polio, measles, and hepatitis B. The company focuses on technology integration for medical and pharmaceutical microneedle development. It also provides fundamental MAP research through prototyping to MAP production for clinical trials. The company was incorporate...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2016
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 464490

Financial Performance

In 2025, QuadMedicine's revenue was 10.70 billion, an increase of 14.99% compared to the previous year's 9.30 billion. Losses were -6.93 billion, 39.5% more than in 2024.